Table 3. Preferred evidence (assessment criteria) interviewees in UK, Germany, Italy, and Spain indicated they would like to see to support decisions on adoption of RM.

Criteria		UK	Germany	Italy	Spain
Clinical	Observational data comparing two cohorts of patients (e.g. comparing effectiveness and safety of RM versus usual care, or RM + standard of care versus standard of care alone)	✓	✓	✓
Clinical	Positive patient mortality		✓
Clinical	Real life data on effectiveness, safety and patient compliance			✓
Health Economics	Cost-utility data	✓		✓
Health Economics	Budget impact model			✓
Health Economics	Cost per incident/intervention avoided	✓			✓
Health Economics	Cost-effectiveness data		✓	✓
Health Economics	Cost-benefit analysis over time			✓
Health Economics	Reduction in healthcare resource utilisation		✓
Other	Evidence of patient satisfaction	✓			✓
Other	RM offers additional value (e.g. early diagnosis and analytics)				✓